Accuray (ARAY) Registration Filing summary

Company overview and business model

• Develops, manufactures, sells, and supports advanced radiation therapy solutions for complex and common cases, aiming to improve accuracy, flexibility, and patient outcomes.

• Key technologies include CyberKnife and TomoTherapy platforms, with the Radixact System as the next-generation TomoTherapy platform.

• Offers services such as post-contract support, installation, training, and professional services.

• Incorporated in California in 1990, reincorporated in Delaware in 2007, with principal offices in Madison, WI, and Santa Clara, CA.

Use of proceeds and capital allocation

• Will not receive proceeds from the resale of shares by selling stockholders; proceeds from any cash exercise of warrants will be used for general corporate purposes.

Risk factors and disclosures

• Investment involves a high degree of risk, with detailed risks incorporated by reference from recent annual and quarterly reports.

• Risks include those that could materially and adversely impact business, operating results, and financial condition.